J Neurooncol. 2021 May;153(1):89-98. doi: 10.1007/s11060-021-03747-1. Epub 2021 Apr 06.
Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints.
Journal of neuro-oncology
Pim B van der Meer, Johan A F Koekkoek, Martin J van den Bent, Linda Dirven, Martin J B Taphoorn
Affiliations
Affiliations
- Department of Neurology, Leiden University Medical Center, PO BOX 9600, Leiden, 2300 RC, The Netherlands. [email protected].
- Department of Neurology, Leiden University Medical Center, PO BOX 9600, Leiden, 2300 RC, The Netherlands.
- Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands.
- Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.
PMID: 33822293
PMCID: PMC8131297 DOI: 10.1007/s11060-021-03747-1
Abstract
INTRODUCTION: AEDs have been associated with depression, anxiety, and cognitive impairment, all frequent complications of glioma and its subsequent treatment, with considerable morbidity and an adverse effect on health-related quality of life. This study aimed to determine the independent association between AED use and self-reported depression, anxiety, and subjective cognitive impairment in glioma patients.
METHODS: In this multicenter cross-sectional study, depression and anxiety were assessed with the HADS and subjective cognitive impairment was assessed with the MOS-CFS. Univariable logistic regression analyses were performed on all potential confounding predictor variables. Potential confounders were included in the multivariable analyses if p-value < 0.1, to evaluate whether use of AEDs was independently related to depression, anxiety, and/or subjective cognitive impairment.
RESULTS: A total of 272 patients were included. Prevalence of depression differed significantly between patients not using (10%) and using AEDs (21%, unadjusted Odds Ratio [uOR] = 2.29 [95%CI 1.05-4.97], p = 0.037), but after correction for confounders the statistical significant difference was no longer apparent (adjusted Odds Ratio [aOR] = 1.94 [95%CI 0.83-4.50], p = 0.125). Prevalences of anxiety (aOR = 1.17 [95%CI 0.59-2.29], p = 0.659) and subjective cognitive impairment (aOR = 0.83 [95%CI 0.34-2.04], p = 0.684) did not differ significantly before or after adjustment of confounders between patients not using (19% and 16%, respectively) and using AEDs (26% and 21%, respectively).
CONCLUSIONS: Our results indicate AED use was not independently associated with concurrent depression, anxiety, or subjective cognitive impairment in glioma patients. Alternative factors seem to have a greater contribution to the risk of developing neuropsychiatric symptoms in glioma patients.
Keywords: Anticonvulsants; Anxiety; Cognition; Depression; Glioma; Seizures
References
- Oncologist. 2014 Jul;19(7):751-9 - PubMed
- Neuro Oncol. 2012 Sep;14 Suppl 4:iv17-24 - PubMed
- J Neurooncol. 2018 Dec;140(3):739-748 - PubMed
- Neurology. 2000 May 23;54(10):1886-93 - PubMed
- Clin Pharmacol Ther. 1997 Dec;62(6):592-5 - PubMed
- J Neurol. 2018 Jun;265(6):1432-1442 - PubMed
- PLoS One. 2017 Jul 17;12(7):e0180470 - PubMed
- Acta Psychiatr Scand. 1983 Jun;67(6):361-70 - PubMed
- Seizure. 2007 Jun;16(4):296-304 - PubMed
- Epilepsy Behav. 2004 Feb;5 Suppl 1:S66-76 - PubMed
- BMC Med Res Methodol. 2008 Oct 30;8:70 - PubMed
- Epilepsia. 2013 Dec;54 Suppl 9:97-104 - PubMed
- Epilepsy Res. 2001 Apr;44(1):53-63 - PubMed
- Neuro Oncol. 2013 Feb;15(2):216-23 - PubMed
- J Pain Symptom Manage. 1995 Feb;10(2):131-41 - PubMed
- Lancet Neurol. 2009 Sep;8(9):810-8 - PubMed
- J Clin Oncol. 2001 Oct 15;19(20):4037-47 - PubMed
- Lancet Neurol. 2007 May;6(5):421-30 - PubMed
- Am J Epidemiol. 2007 Mar 15;165(6):710-8 - PubMed
- Eur J Neurol. 2017 Oct;24(10):1283-1289 - PubMed
- Psychol Med. 1997 Mar;27(2):363-70 - PubMed
- JAMA Neurol. 2019 Apr 1;76(4):440-446 - PubMed
- Ann Neurol. 2003 Oct;54(4):514-20 - PubMed
- Drugs. 2002;62(4):593-604 - PubMed
- Lancet. 2002 Nov 2;360(9343):1361-8 - PubMed
- Epilepsy Behav. 2017 Nov;76:24-31 - PubMed
- J Natl Cancer Inst. 2011 Jan 5;103(1):61-76 - PubMed
- Epilepsy Behav. 2008 Nov;13(4):642-9 - PubMed
- Eur J Cancer. 1998 Jan;34(1):98-102 - PubMed
- Nat Clin Pract Neurol. 2006 Sep;2(9):494-503; quiz 1 p following 516 - PubMed
- J Neurol Neurosurg Psychiatry. 2014 Feb;85(2):230-5 - PubMed
- Neurooncol Pract. 2015 Mar;2(1):20-31 - PubMed
- J Nurs Scholarsh. 2007;39(1):61-7 - PubMed
- Neuro Oncol. 2016 Jun;18(6):779-89 - PubMed
- Am J Phys Med Rehabil. 2001 May;80(5):346-50 - PubMed
- J Clin Oncol. 2011 Nov 10;29(32):4307-12 - PubMed
- Neuro Oncol. 2012 Apr;14(4):392-404 - PubMed
- J Neurol. 2017 May;264(5):921-927 - PubMed
- Lancet Neurol. 2004 Mar;3(3):159-68 - PubMed
- Acta Neuropathol. 2016 Jun;131(6):803-20 - PubMed
- J Infus Nurs. 2004 Jul-Aug;27(4):263-9 - PubMed
Publication Types